Magid Abou-Gharbia, Ph.D.

 

Magid Abou-Gharbia is currently Professor of Medicinal Chemistry and Director of Temple University’s Center for Drug Discovery Research. He recently retired from Wyeth Research as senior vice president of Chemical and Screening Sciences, following a very successful 26-year career, where he built a strong multi-disciplinary organization. During his tenure he fostered a highly creative environment based on modern drug discovery technologies and enhanced chemistry skills and capabilities via the recruitment of high caliber scientists. Under his leadership, his group research efforts led to the discovery of six marketed drugs and many compounds currently under clinical evaluation including: first-in-class antidepressant Effexor®; Anticancer Agent Mylotarg®, a sedative hypnotic Sonata®; a broad spectrum antibiotic Tygacil®, an anticancer rapamycin derivative, Torisel™ and an SNRI antidepressant, Pristiq®. His scientific accomplishments include over 175 invited lectures, presentations and publications. He is an inventor on 99 issued US patents and over 350 patents worldwide. As a result of this Magid was named in list of most prolific inventors by US Patent & Trademark association. He received a number of awards, including the Alfred Burger Award in Medicinal Chemistry (2008), American Institute of Chemists (AIC) Chemistry Pioneer Award (2007), Researcher of the Year (2006) from Health Care Institute of NJ (HINJ); Trailblazer Award (2006) from Science Spectrum; Induction into the New Jersey Inventors Hall of Fame (2004); the Procter Medal (2003); ACS Earle B. Barnes Award (2001); Philadelphia Organic Chemists Club (POCC) Award (2001); Egyptian Pharmaceutical Society Drug Discovery Award (2000). As a mentor, Magid developed leaders at all levels throughout Chemical and Screening Sciences. He actively encouraged his colleagues at Wyeth to contribute to and participate in American Chemical Society activities, and was a strong supporter of the Division of Medicinal Chemistry in the form of session, meeting and graduate fellowship sponsorship.